Navigation Links
Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women
Date:9/25/2011

Stockholm, Sweden: A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer Congress [1] today (Sunday). Researchers think it could be the key for a greater understanding of the mechanisms of breast cancer recurrence as well as offering new options for patient care.

Zoledronic acid is one of the bisphosphonates, a group of drugs mainly used to treat osteoporosis. However they are also given to cancer patients to protect against the effects of secondary bone cancer, such as pain and weakness in the bones. Laboratory studies have suggested that zoledronic acid might also have direct anti-tumour effects and enhance other chemotherapy treatments, so the multi-centre AZURE trial was set up to investigate further.

Led by Professor Robert Coleman at the Weston Park Hospital in Sheffield, UK, the trial recruited 3,360 patients with stage II/III breast cancer from 174 centres. They were randomised to receive chemotherapy and/or endocrine therapy, with or without zoledronic acid. An interim analysis of the trial's progress indicated that patients were seeing no clinical benefit from the treatment, so the data were released for more detailed scrutiny.

This confirmed the drug's lack of impact, apart from in a sub-set of women who had undergone menopause five or more years previously. Here, the overall survival rate was 85% compared to 79% for women who did not receive zoledronic acid. The effect was independent of the characteristics of the disease as shown by the stage of the tumour, oestrogen receptor status, and lymph node involvement.

"This is a small but significant increase," Prof Coleman explains. "The finding is not sufficient to be taken up on its own but in the context of other studies and additional data anticipated later in the year, it is likely to change pract
'/>"/>

Contact: Saffina Rana
saffina.rana@europe.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Bone drug zoledronic acid may help prevent spread of early lung cancer
2. Service Foods Reduces its Carbon Footprint and Grows Sales
3. Health Care Reform Report Covers Uninsured, Reduces Costs
4. New cardiac CT technology drastically reduces patient radiation exposure
5. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
6. Targeted delivery of losartan reduces liver inflammation and scarring
7. Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
8. Soccer reduces risk of falls and bone fractures
9. Pioneering treatment reduces disability in premature babies with serious brain hemorrhage
10. New drug candidate reduces blood lipids
11. PSA Test Reduces Prostate Cancer Deaths by 40%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... KY (PRWEB) April 24, 2015 Anchor ... for Medical Field Professionals, today announced their exclusive agreement ... national Long Term Care Insurance distribution partner. , Anchor ... Long Term Care Insurance benefits for associations, and is ... for its Long Term Care Insurance member benefit. ...
(Date:4/24/2015)... 2015 “Kind,” “selfless,” “the voice of ... ways Denise Weiner described pediatric oncology nurse Laura Vasquez ... daughter, Alexa, during her five-year battle with a malignant ... marrow transplant and numerous experimental treatments, Vasquez continued caring ... when she was not in the hospital and even ...
(Date:4/24/2015)... National Access Cannabis (NAC), ... to medical cannabis, is taking a leadership role in ... patients. , NAC is the first to back mdBriefCase ... grant, NAC will be providing 300 healthcare professionals with ... to help Canadians gain safe and responsible access to ...
(Date:4/24/2015)... MMJ Physician Practice in Salem, ... to enroll in the Massachusetts medical marijuana program.    Their ... away from Alternative Therapies Group (ATG), the first ... summer. With the dispensary nearby, MMJ Physician ... for residents of eastern Massachusetts to enroll in ...
(Date:4/24/2015)... (PRWEB) April 24, 2015 Qualis ... management organizations, has published a new resource for ... Guide.” The guide to Quality and Resource Use ... Medicaid & Medicare Services (CMS) to help practices ... care, streamline resources, and identify care coordination opportunities ...
Breaking Medicine News(10 mins):Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:National Access Cannabis Gives 300 Canadian Healthcare Professionals Access to Medical Cannabis Certificate Program 2Health News:Medical Doctor from Salem Massachusetts Supports the Medical Marijuana Industry 2Health News:Qualis Health Publishes Guide to Help Physician Practices Assess and Improve Quality 2
... HealthDay Reporter , WEDNESDAY, March 23 (HealthDay ... of predicting when breast cancer will spread. Two ... distinguish more aggressive cancers from less aggressive ones, according ... not involve changes to the sequencing of the genes ...
... ANGELESBefore undergoing elective surgery, patients should consider waiting longer after ... study scheduled for publication in the May issue of the ... Association and the American College of Cardiology recommend patients wait ... before undergoing elective surgery. This guidance is based on studies ...
... , WEDNESDAY, March 23 (HealthDay News) -- People with ... bronchodilators to control symptoms and reduce flare-ups, but which ... Now results have arrived from a new study that ... to determine their effectiveness at controlling the disease, which ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, March ... they weigh less than they do, and many mothers of ... finds. The study of women and children conducted at ... faulty body image was far more prevalent among the heaviest ...
... Reporter , WEDNESDAY, March 23 (HealthDay News) -- The Affordable ... health-care reform package -- the centerpiece of President Barack Obama,s ... day it was signed into law. "The worst law ... of Consumers for Health Care Choices, a national nonprofit group ...
... hematologist Edward J. Benz Jr., M.D., is the 2011 recipient ... Women in Cancer Medicine and Cancer Science presented by The ... and chief executive officer of Dana-Farber Cancer Institute, receives the ... The first male recipient of the Kripke Legend Award, ...
Cached Medicine News:Health News:Genes' 'On/Off' Switches Yield Clues to Breast Cancer 2Health News:Genes' 'On/Off' Switches Yield Clues to Breast Cancer 3Health News:Outcomes improved by longer delays between heart attacks and elective surgeries 2Health News:For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial 2Health News:For Lung Disorder, Spiriva Beat Serevent in Head-to-Head Trial 3Health News:Many Obese Moms and Kids Underestimate Their Weight 2Health News:Many Obese Moms and Kids Underestimate Their Weight 3Health News:As Health Care Reform Turns 1, Backers and Detractors Dig In 2Health News:As Health Care Reform Turns 1, Backers and Detractors Dig In 3Health News:As Health Care Reform Turns 1, Backers and Detractors Dig In 4Health News:Benz wins Kripke Award for promoting women in science, medical careers 2
(Date:4/24/2015)... April 24, 2015  New technologies and online ... to educate themselves about products and companies. Likewise, ... techniques available to market researchers seeking insights into ... marketplace, it,s imperative that organizations adjust their consumer ... market opportunities, niches and growth fronts. ...
(Date:4/24/2015)... , Apr. 24, 2015 Research and Markets ... the "Global Biobanking Market 2015-2019" report to ... Biobanking market to grow at a CAGR of 7.07% ... market can be divided into two segments: Equipment and ... growth prospects of the Global Biobanking market for the ...
(Date:4/24/2015)... Hi-Tech Pharmaceuticals refutes the results from ... of reliable scientific principles and methods and therefore ... of adulteration. The FDA is resting its very, ... misguided hope, that Methylphenylethylamine is not found in ... multiple other studies and cannot be relied on ...
Breaking Medicine Technology:Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2Global Biobanking Market Report 2015-2019 - Increase in Strategic Collaborations with Beckman Coulter, Tecan & Thermo Fischer Scientific Dominating 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: